Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL38 pseudogene 1 (RPL38P1) is a non-coding genomic DNA sequence derived from retrotransposition of the RPL38 gene, which encodes the 60S ribosomal protein L38, a component of the large ribosomal subunit. This pseudogene has lost coding capacity and does not produce a functional protein. An unusual form of the RPL38 pseudogene is located in the promoter region of the type 1 angiotensin II receptor gene in humans[2][3]. Unlike the parental RPL38, which is involved in ribosome function and developmental regulation, the pseudogene RPL38P1 has no known biological function, disease association, or interaction with drugs, and it is not considered a therapeutic target[2][3]. Pseudogenes like RPL38P1 are typically transcriptionally silent and lack the ability to serve as molecular drug targets. The parent gene, RPL38, is essential for ribosome structure and protein synthesis, but the pseudogene itself does not contribute to these functions[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL38 pseudogene 1 (RPL38P1).